Epilepsy and cannabidiol: a guide to treatment.

Address: Paediatric Epilepsy Dpt., University Hospitals of Lyon (HCL), Member of the ERN EpiCARE, and Inserm U1028/CNRS UMR5292, Lyon, France; Department of Neuropediatrics, University Hospital Jena, Jena, Germany; UCL NIHR BRC Great Ormond Street Institute of Child Health, Member of the ERN EpiCARE, London, UK; Hospital Ruber Internacional, Epilepsy program, Madrid, Spain; University Hospitals KULeuven, Department Development and Regeneration, Section Pediatric Neurology, Member of the ERN EpiCARE, Leuven Belgium; Program for Pharmacy, Oslo Metropolitan University and The National Center for Epilepsy and Dept of Pharmacology, Oslo University Hospital, Norway; Rare and Complex Epilepsy Unit, Department on Neuroscience, Bambino Gesu' Children's Hospital, IRCCS, Member of the ERN EpiCARE, Rome, Italy; Pediatric neurology department, Reference centre for rare epilepsies, Member of the ERN EpiCARE, Necker Enfants Malades University Hospital, APHP, Inserm UMR1163, Institut Imagine, Paris Descartes University, Paris, France; Department of Neurology, Massachusetts General Hospital, Boston, USA; Paediatric Epilepsy Dpt., University Hospitals of Lyon (HCL), Member of the ERN EpiCARE, and Inserm U1028 / CNRS UMR5292, Lyon, France; Université Paris Diderot, Sorbonne Paris Cité, INSERM UMR1141, Paris; AP-HP, Hôpital Robert Debré, Service de Neurologie Pédiatrique, Paris; Carreño Hospital Clínic - Epilepsy Unit, Department of Neurology; Member of the European Reference Network on Rare and Complex epilepsies, ERN EpiCARE, Barcelona, Spain; Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences and MRC Centre for Reproductive Health, The University of Edinburgh, Edinburgh, UK; Neurosciences, Royal Hospital for Sick Children, Edinburgh, UK; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States; Department of Pediatrics, Catholic University of Leuven, Brussels, Belgium; Institute for Experimental and Clinical Research, Catholic University of Leuven, Brussels, Belgium; Endocannabinoid Research Group, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Pozzuoli (NA) 80078 IT, Italy; Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health, Institut Universitaire de Cardiologie et de Pneumologie de Québec and Institut sur la Nutrition et les Aliments Fonctionnels, Université Laval, Quebec City G1V 0A6, Canada; Hospital Sant Joan de Deu, Esplugues de Llobregat, Espana; Department of Paediatric Neurology, Evelina London Children's Hospital; Department of Child Neurology, Brain Center, University medical Center Utrecht, Member of the European Reference Network EpiCARE, The Netherlands; School of Medicine, University of Eastern Finland, Kuopio, Finland; Epilepsy Center/Neuro Center, Kuopio University Hospital, Kuopio, Finland; Pediatric Neurology Unit, Wolfson Medical Center, Holon and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of Developmental Neurology, Medical University of Gdansk, Gdansk, Poland; Rare and Complex Epilepsy Unit, Division of Neurology, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy; Department of Neuropediatrics, University Children's Hospital, Zürich, Switzerland; TIGER, Neuroscience Research Center of Lyon, INSERM U1028, CNRS 5292 Lyon, France; Clínica Universidad de Navarra, Pediatric Neurology Unit, Pio XII, 36, 31080, Pamplona, Spain; Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto “G. Gaslini”, Genova; GW Research Ltd, Chivers Way, Histon, Cambridge, United Kingdom